2011
DOI: 10.1001/archdermatol.2011.159
| |Summarize |Cite
|
Sign up to set email alerts

Malignant Melanoma in Solid Transplant Recipients

Abstract: To determine malignant melanoma causespecific and overall survival among patients with melanoma diagnosed after organ transplantation compared with a national sample with malignant melanoma.

Search citation statements

Order By: Relevance

Paper Sections

Select...
85
6
5
1

Citation Types

1
37
0
1

Year Published

Range
2012
2012
2026
2026

Publication Types

Select...
66
18
10

Relationship

1
93

Authors

Journals

Cited by 94 publications

(39 citation statements)

References 24 publications

1
37
0
1
Order By: Relevance
How the paper below cites the one you are viewing
“…Our survival analysis supports a further role for immune response in controlling melanoma progression after clinical diagnosis. Transplant recipients had a three-fold increased risk of dying from their melanoma compared with melanoma patients without a transplant; this is generally consistent with most ( Vajdic et al , 2014 ; Brewer et al , 2011 ), but not all ( Matin et al , 2008 ), prior studies. The strong association for localized tumors – including for thin tumors with Breslow thickness <1 mm – implies that there may be subclinical spread of these tumors in transplant recipients, and in turn, that intact immune responses may normally prevent this spread.…”
Section: Discussion
supporting
confidence: 84%